Compounds > 3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol
Page last updated: 2024-09-03

3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol and hirudin

3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol has been researched along with hirudin in 1 studies

Compound Research Comparison

Studies
(3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol)		Trials
(3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol)		Recent Studies (post-2010)
(3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol)		Studies
(hirudin)		Trials
(hirudin)		Recent Studies (post-2010) (hirudin)
1174323,658378995

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, Y; Lu, WL; Meng, M; Wang, JC; Wang, XQ; Wang, YB; Zhang, H; Zhang, Q; Zhang, X1

Other Studies

1 other study(ies) available for 3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol and hirudin

ArticleYear
Increase of the pharmacological and pharmacokinetic efficacy of negatively charged polypeptide recombinant hirudin in rats via parenteral route by association with cationic liposomes.
    Journal of controlled release : official journal of the Controlled Release Society, 2008, Jun-04, Volume: 128, Issue:2

    Topics: Amines; Animals; Biological Availability; Blood Coagulation; Cations; Cholesterol; Fibrinolytic Agents; Hirudins; Infusions, Parenteral; Lecithins; Male; Partial Thromboplastin Time; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Static Electricity; Thrombin Time; Unilamellar Liposomes

2008